Sphera Funds Management as of Dec. 31, 2022
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 64 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Invesco Qqq Tr Call Call Option | 13.2 | $62M | 231k | 266.28 | |
Invesco Qqq Tr Put Put Option | 12.0 | $56M | 210k | 266.28 | |
Astrazeneca Sponsored Adr (AZN) | 5.8 | $27M | 400k | 67.80 | |
Sanofi Sponsored Adr (SNY) | 5.8 | $27M | 560k | 48.43 | |
Teva Pharmaceutical Inds Call Call Option | 4.3 | $20M | 2.2M | 9.12 | |
Johnson & Johnson (JNJ) | 4.2 | $19M | 110k | 176.65 | |
Syndax Pharmaceuticals (SNDX) | 3.9 | $18M | 711k | 25.45 | |
Merck & Co (MRK) | 2.9 | $13M | 121k | 110.95 | |
Crinetics Pharmaceuticals In (CRNX) | 2.6 | $12M | 672k | 18.30 | |
Albireo Pharma | 2.2 | $10M | 464k | 21.61 | |
Abbvie (ABBV) | 2.1 | $9.7M | 60k | 161.61 | |
Novo-nordisk A S Adr (NVO) | 2.1 | $9.7M | 72k | 135.34 | |
Eli Lilly & Co. (LLY) | 2.0 | $9.4M | 26k | 365.84 | |
Kezar Life Sciences | 2.0 | $9.2M | 1.3M | 7.04 | |
Ultragenyx Pharmaceutical (RARE) | 1.8 | $8.5M | 184k | 46.33 | |
Springworks Therapeutics (SWTX) | 1.8 | $8.2M | 317k | 26.01 | |
Keros Therapeutics (KROS) | 1.6 | $7.6M | 159k | 48.02 | |
Arcellx Common Stock (ACLX) | 1.6 | $7.4M | 238k | 30.98 | |
Astria Therapeutics (ATXS) | 1.5 | $7.0M | 469k | 14.89 | |
Tower Semiconductor Put Put Option | 1.5 | $7.0M | 162k | 43.20 | |
Point Biopharma Global | 1.5 | $6.9M | 953k | 7.29 | |
Kura Oncology (KURA) | 1.5 | $6.9M | 558k | 12.41 | |
Immatics SHS (IMTX) | 1.5 | $6.8M | 781k | 8.71 | |
Cincor Pharma | 1.4 | $6.5M | 530k | 12.29 | |
Five9 (FIVN) | 1.4 | $6.4M | 95k | 67.86 | |
Altimmune Com New (ALT) | 1.3 | $6.3M | 380k | 16.45 | |
Concert Pharmaceuticals I equity | 1.3 | $5.9M | 1.0M | 5.84 | |
Spdr Ser Tr S&p Biotech (XBI) | 1.2 | $5.8M | 70k | 83.00 | |
Generac Holdings (GNRC) | 1.1 | $5.0M | 50k | 100.66 | |
Merus N V (MRUS) | 1.1 | $4.9M | 317k | 15.47 | |
Kiniksa Pharmaceuticals Com Cl A | 1.0 | $4.6M | 307k | 14.98 | |
D R S Technologies (DRS) | 0.9 | $4.3M | 336k | 12.78 | |
Iveric Bio | 0.9 | $4.2M | 196k | 21.41 | |
Bellus Health Com New | 0.9 | $4.0M | 490k | 8.22 | |
Fiverr Intl Note 11/0 | 0.9 | $4.0M | 5.0M | 0.81 | |
Rigel Pharmaceuticals Com New | 0.7 | $3.4M | 2.3M | 1.50 | |
Chinook Therapeutics | 0.7 | $3.3M | 127k | 26.20 | |
Apellis Pharmaceuticals Put Put Option | 0.7 | $3.1M | 60k | 51.71 | |
Camtek Ord (CAMT) | 0.5 | $2.4M | 110k | 21.96 | |
Rezolute Com New (RZLT) | 0.5 | $2.4M | 1.2M | 2.07 | |
89bio (ETNB) | 0.5 | $2.3M | 181k | 12.73 | |
Biogen Idec (BIIB) | 0.4 | $2.1M | 7.5k | 276.92 | |
Stoke Therapeutics (STOK) | 0.4 | $1.7M | 189k | 9.23 | |
Inozyme Pharma (INZY) | 0.4 | $1.7M | 1.6M | 1.05 | |
Pmv Pharmaceuticals (PMVP) | 0.4 | $1.6M | 188k | 8.70 | |
Bioatla (BCAB) | 0.3 | $1.5M | 187k | 8.25 | |
Alpine Immune Sciences | 0.3 | $1.5M | 200k | 7.35 | |
Werewolf Therapeutics (HOWL) | 0.3 | $1.3M | 627k | 2.05 | |
Mediwound Shs New (MDWD) | 0.2 | $1.0M | 75k | 13.49 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $950k | 500k | 1.90 | |
Applied Materials (AMAT) | 0.2 | $828k | 8.5k | 97.37 | |
Infinity Pharmaceuticals (INFIQ) | 0.2 | $819k | 1.5M | 0.56 | |
Nice Sys Note 1.250% 1/1 | 0.1 | $577k | 250k | 2.31 | |
Taboola.com Ord Shs (TBLA) | 0.1 | $370k | 120k | 3.08 | |
Magic Software Enterprises L Ord (MGIC) | 0.1 | $352k | 22k | 16.02 | |
Immatics *w Exp 07/01/202 (IMTXW) | 0.1 | $251k | 100k | 2.51 | |
Aeglea Biotherapeutics | 0.0 | $198k | 441k | 0.45 | |
Cyclacel Pharmaceuticals | 0.0 | $167k | 250k | 0.67 | |
Otonomo Technologies Ordinary Shares | 0.0 | $160k | 392k | 0.41 | |
Arbe Robotics Ordinary Shares (ARBE) | 0.0 | $147k | 43k | 3.41 | |
Oncorus | 0.0 | $137k | 540k | 0.25 | |
Dyne Therapeutics (DYN) | 0.0 | $83k | 7.1k | 11.59 | |
89bio Call Call Option | 0.0 | $46k | 3.6k | 12.73 | |
Outbrain (OB) | 0.0 | $44k | 12k | 3.62 |